Cerebrospinal Fluid Biomarkers and Amyloid-β Elimination from the Brain in Cerebral Amyloid Angiopathy-Related Inflammation
Journal of Alzheimer's Disease · 31.01.2023 · 91 (3) · 1173-1183
DOI: 10.3233/jad-220838 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, erschienen am 31.01.2023. Verfasst von Kenji Sakai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Joetsu General Hospital, Joetsu, Japan. Hauptthemen laut MEDLINE: Cerebral Amyloid Angiopathy, Alzheimer Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Background
Cerebrospinal fluid (CSF) biomarkers in patients with cerebral amyloid angiopathy-related inflammation (CAA-ri) have demonstrated inconsistent results.
Objective
We investigated the relationship between CSF amyloid-β protein (Aβ) and vascular pathological findings to elucidate the mechanisms of Aβ elimination from the brain in CAA-ri.
Methods
We examined Aβ40 and Aβ42 levels in CSF samples in 15 patients with CAA-ri and 15 patients with Alzheimer’s disease and cerebral amyloid angiopathy (AD-CAA) using ELISA as a cross-sectional study. Furthermore, we pathologically examined Aβ40 and Aβ42 depositions on the leptomeningeal blood vessels (arteries, arterioles, and veins) using brain biopsy samples from six patients with acute CAA-ri and brain tissues of two autopsied patients with CAA-ri.
Results
The median Aβ40 and Aβ42 levels in the CSF showed no significant difference between pre-treatment CAA-ri (Aβ40, 6837 pg/ml; Aβ42, 324 pg/ml) and AD-CAA (Aβ40, 7669 pg/ml, p = 0.345; Aβ42, 355 pg/ml, p = 0.760). Aβ40 and Aβ42 levels in patients with post-treatment CAA-ri (Aβ40, 1770 pg/ml, p = 0.056; Aβ42, 167 pg/ml, p = 0.006) were lower than those in patients with pre-treatment CAA-ri. Regarding Aβ40 and Aβ42 positive arteries, acute CAA-ri cases showed a higher frequency of partially Aβ-deposited blood vessels than postmortem CAA-ri cases (Aβ40, 20.8% versus 3.9%, p = 0.0714; Aβ42, 27.4% versus 2.0%, p = 0.0714, respectively).
Conclusion
Lower levels of CSF Aβ40 and Aβ42 could be biomarkers for the cessation of inflammation in CAA-ri reflecting the recovery of the intramural periarterial drainage pathway and vascular function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Joetsu General Hospital, Joetsu, Japan.
- Department of Neurology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
- Department of Preemptive Medicine for Dementia, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
- Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
- Department of Neurology, Kanazawa Medical University, Uchinada, Japan.
- Department of Internal Medicine, Kudanzaka Hospital, Tokyo, Japan.
Zitieren
APA
Sakai, K., Noguchi-Shinohara, M., Tanaka, H., Ikeda, T., Hamaguchi, T., Kakita, A., Yamada, M., & Ono, K. (2023). Cerebrospinal Fluid Biomarkers and Amyloid-β Elimination from the Brain in Cerebral Amyloid Angiopathy-Related Inflammation. Journal of Alzheimer's Disease, 91(3), 1173-1183. https://doi.org/10.3233/jad-220838
Vancouver
Sakai K, Noguchi-Shinohara M, Tanaka H, Ikeda T, Hamaguchi T, Kakita A, et al. Cerebrospinal Fluid Biomarkers and Amyloid-β Elimination from the Brain in Cerebral Amyloid Angiopathy-Related Inflammation. Journal of Alzheimer's Disease. 2023;91(3):1173-1183. doi:10.3233/jad-220838
BibTeX
@article{Sakai2023,
author = {Sakai, Kenji and Noguchi-Shinohara, Moeko and Tanaka, Hidetomo and Ikeda, Tokuhei and Hamaguchi, Tsuyoshi and Kakita, Akiyoshi and Yamada, Masahito and Ono, Kenjiro},
title = {Cerebrospinal Fluid Biomarkers and Amyloid-β Elimination from the Brain in Cerebral Amyloid Angiopathy-Related Inflammation},
journal = {Journal of Alzheimer's Disease},
year = {2023},
volume = {91},
number = {3},
pages = {1173--1183},
doi = {10.3233/jad-220838}
}
EUVIMED